2018
DOI: 10.1038/s41467-017-02175-y
|View full text |Cite
|
Sign up to set email alerts
|

Molecular snapshots of APE1 proofreading mismatches and removing DNA damage

Abstract: Human apurinic/apyrimidinic (AP) endonuclease 1 (APE1) is an essential DNA repair enzyme which uses a single active site to process DNA damage via two distinct activities: (1) AP-endonuclease and (2) 3′ to 5′ exonuclease. The AP-endonuclease activity cleaves at AP-sites, while the exonuclease activity excises bulkier 3′ mismatches and DNA damage to generate clean DNA ends suitable for downstream repair. Molecular details of the exonuclease reaction and how one active site can accommodate various toxic DNA repa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

12
108
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 99 publications
(120 citation statements)
references
References 61 publications
12
108
0
Order By: Relevance
“…This substrate overlap implies a level of evolved redundancy among enzymes that may play a particular biological role during different cellular stages and in response to varying types of DNA damage. Despite this ambiguity and overlap, the biological relevance of the APE1 exonuclease activity has been identified in several instances, including: (1) APE1 removal of 3ʹ α,β-unsaturated aldehyde (PUA) groups resulting from bi-functional glycosylases during BER [ 54 ]; (2) the cleansing of oxidatively damaged DNA dirty ends, such as 3ʹ PG (phosphoglycolate) and 3ʹ 8-oxoG (8-oxoGuanine) by APE1 both in vitro and in cellular extracts [ 55 , 56 ]; (3) APE1 proofreading of DNA ligation confounding misinsertions by DNA polymerase β during BER, [ 11 , [57] , [58] , [59] ]; and (4) the association between APE1 variants with reduced exonuclease activity and carcinogenesis [ [60] , [61] , [62] ]. Below, we will discuss intriguing biological models for some of these APE1 scenarios and how one protein active site can accommodate an array of nucleic acid substrates.…”
Section: Ape1 Dna 3ʹ End Processing Activitiesmentioning
confidence: 99%
See 4 more Smart Citations
“…This substrate overlap implies a level of evolved redundancy among enzymes that may play a particular biological role during different cellular stages and in response to varying types of DNA damage. Despite this ambiguity and overlap, the biological relevance of the APE1 exonuclease activity has been identified in several instances, including: (1) APE1 removal of 3ʹ α,β-unsaturated aldehyde (PUA) groups resulting from bi-functional glycosylases during BER [ 54 ]; (2) the cleansing of oxidatively damaged DNA dirty ends, such as 3ʹ PG (phosphoglycolate) and 3ʹ 8-oxoG (8-oxoGuanine) by APE1 both in vitro and in cellular extracts [ 55 , 56 ]; (3) APE1 proofreading of DNA ligation confounding misinsertions by DNA polymerase β during BER, [ 11 , [57] , [58] , [59] ]; and (4) the association between APE1 variants with reduced exonuclease activity and carcinogenesis [ [60] , [61] , [62] ]. Below, we will discuss intriguing biological models for some of these APE1 scenarios and how one protein active site can accommodate an array of nucleic acid substrates.…”
Section: Ape1 Dna 3ʹ End Processing Activitiesmentioning
confidence: 99%
“…Substrates for end processing enzymes are indicated in parentheses. Enzyme k cat /K M (s −1 μM -1 ) Reference End Processing Enzymes APE1 (3'-PUA) 2.7 [ 54 ] APE1 (3'-Mismatch) 1 [ 1 , 11 ] APE2 (3ʹ-Mismatch) 4 × 10 −6 [ 107 ] PNK (3'-Phosphate) 30 [ 54 ] Tdp1 (3′-Phosphotyrosine) 0.25 [ 108 ] Aprataxin (5'-AMP) 3 [ 109 ] Pol β (5ʹ-dRP lyase) 0.15 [ 110 ] BER Enzymes UNG 500 [ 110 ] OGG1 0.03 [ 110 ] APE1 (AP-DNA) 100 [ 110 ] pol β (insertion) 1.5 [ 110 ] Pol β (5ʹ-dRP lyase) 0.15 [ 110 ] Lig I 0.4 [ ...…”
Section: Ape1 Dna 3ʹ End Processing Activitiesmentioning
confidence: 99%
See 3 more Smart Citations